In osteosarcoma, BCA inhibited the growth of osteosarcoma cells by activating caspase 9 and caspase 3 and by increasing the ratio of Bax:Bcl-2/Bcl-XL (Figure 4) [7]. Here, CASP9 is linked to osteosarcoma.